Testing how genetics affect GLP-1 response in prediabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how your genes may change how well a GLP-1–type medicine works to improve prediabetes. It focuses on adults at higher risk of developing diabetes, especially people of Mexican-American background.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- You have prediabetes based on your recent blood tests (A1C, fasting glucose, and/or glucose tolerance test)
- You’re at higher risk for diabetes, such as having obesity (BMI 30+), and/or certain blood pressure or cholesterol/triglyceride or fasting glucose results
- You can’t already have diabetes (Type 1 or Type 2)
- Your recent bloodwork shows adequate kidney and liver function (specific lab cutoffs) and your blood count isn’t too low
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.
This trial tests whether certain diabetes medications can help prevent worsening of heart disease in people who have prediabetes (higher than normal blood sugar, but not yet diabetes). It may be a good fit if you have known coronary artery disease and prediabetes.
This study tests whether a new medication called chiglitazar sodium, combined with a lifestyle program, can help reverse prediabetes (when blood sugar is high but not yet diabetes). It could help you lower your blood sugar and reduce your risk of developing type 2 diabetes.
This trial tests a special drink that may help improve blood sugar levels and gut health in people with prediabetes. It could offer a simple way to manage blood sugar and potentially prevent diabetes.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.